Genesys International Q1 Sales Rise 15%, Profit Falls 24%
Key highlights
- Genesys International reported Q1 FY27 net sales of ₹81.36 crore, up 14.8% year on year.
- Q1 FY27 net profit was ₹5.28 crore, down 24.4% from ₹6.98 crore a year earlier.
- EBITDA declined to ₹29.89 crore in Q1 FY27 from ₹30.77 crore in Q1 FY26.
- The board meeting to consider Q2 FY27 results is scheduled for November 13, 2026.
powered by IRIS

Genesys International Corporation Ltd reported consolidated sales of ₹81.36 crore in Q1 FY27, up 14.8% year on year, while net profit fell 24.4% to ₹5.28 crore. The company is scheduled to consider its Q2 FY27 results for the quarter ended September 30, 2026, at a board meeting on November 13, 2026.
Know Genesys International Corporation inside out
Results, valuation, peers and who's buying, in one view.
What did Genesys International report for Q1 FY27?
Genesys International reported higher sales but lower profitability in the April-June 2026 quarter. Net sales rose to ₹81.36 crore from ₹70.87 crore in the corresponding quarter of the previous year, an increase of 14.8%. However, profit after tax fell to ₹5.28 crore from ₹6.98 crore, a decline of 24.4%.
The reported figures show that revenue growth did not translate into a similar improvement in earnings. Total income stood at ₹83.12 crore, including ₹1.76 crore of other income. Total expenses were ₹53.23 crore, compared with ₹41.37 crore in the June 2025 quarter, while depreciation increased to ₹18.43 crore from ₹15.43 crore.
Which financial metrics changed from the previous year?
The key change was the contrast between sales growth and a decline in operating and net earnings. EBITDA was ₹29.89 crore in Q1 FY27, compared with ₹30.77 crore a year earlier, a fall of about 2.9%, despite the increase in sales. EBITDA in the previous quarter, March 2026, was ₹37.55 crore.
EBIT declined to ₹11.46 crore from ₹15.34 crore in the June 2025 quarter. Interest expense was broadly stable at ₹3.14 crore against ₹3.18 crore a year earlier, but tax expense was ₹3.04 crore. Earnings per share were ₹1.26, down from ₹1.75 in Q1 FY26, according to the reported consolidated quarterly data.
How did the June quarter compare with the March quarter?
Genesys International's June-quarter sales were lower than the ₹104.22 crore recorded in the March 2026 quarter. Net profit also declined from ₹12.72 crore in March 2026 to ₹5.28 crore in June 2026. The sequential comparison shows a lower revenue base and lower profit in the first quarter of FY27.
The quarterly trend has been uneven. Net profit was ₹11.09 crore in September 2024, ₹20.71 crore in December 2024, ₹19 crore in March 2025, ₹6.98 crore in June 2025, ₹12.05 crore in September 2025, ₹1.05 crore in December 2025, and ₹12.72 crore in March 2026. This variation makes the next quarterly filing important for assessing whether the June-quarter profit decline was temporary or part of a continuing pattern.
Got a follow-up? Ask IRIS
When will Genesys International announce Q2 FY27 results?
Genesys International is scheduled to consider and approve unaudited standalone and consolidated results for Q2 FY27 and the half year ended September 30, 2026, on November 13, 2026. The board-meeting notice was filed on November 6, 2026, and identified the meeting as the forum for considering these financial results.
The company reported its Q1 FY27 results on August 14, 2026, 45 days after the June-quarter end. The scheduled Q2 result date falls 44 days after the September-quarter end. The trading window was stated to remain closed until 48 hours after the declaration of the financial results.
Why do the Q1 figures matter to investors?
The Q1 figures matter because sales increased by ₹10.49 crore year on year, but net profit decreased by ₹1.70 crore. Operating profit was ₹28.13 crore, compared with ₹29.50 crore in the prior-year quarter, showing that the rise in sales was accompanied by higher costs and depreciation.
For investors, the next filing will provide the first half-year comparison for FY27 and updated quarterly figures after the June-quarter decline in profit. The available information does not provide guidance or a forecast from the company. Therefore, the reported sales, EBITDA, depreciation, interest costs and profit figures remain the relevant measures for tracking operating performance.
Conclusion
Genesys International began FY27 with 14.8% year-on-year sales growth to ₹81.36 crore, but its ₹5.28 crore net profit was 24.4% below the June 2025 level. EBITDA, EBIT and EPS also declined year on year, indicating that earnings did not keep pace with revenue growth in the reported quarter.
The next disclosed milestone is the November 13, 2026 board meeting for Q2 FY27 and half-year results. Investors will watch the reported sales trend, operating costs, depreciation, EBITDA and net profit when the company files its unaudited standalone and consolidated financial statements.


